Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a 4-Week virtual program help people stop drinking? new study tests remote breathalyzer monitoring

NCT ID NCT05722483

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a 4-week virtual intensive outpatient program for 63 people with moderate to severe alcohol use disorder. The program included group therapy, individual therapy, medication management, and multiple daily breathalyzer checks using facial recognition. The goal was to see if people would stay in the program and find it satisfactory, with a target retention rate of at least 50%.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual intensive outpatient program (cognitive behavioral therapy, DBT skills, health and wellness groups, individual therapy, medication management, and remote breathalyzer monitoring)
What this could lead to
If successful, this could show that a fully virtual program can help people with alcohol use disorder stay abstinent and engaged in treatment, offering a more accessible option than residential care.
What could go wrong
This is a small, single-arm pilot study with no comparison group, so results may not prove effectiveness. The program is intensive and may not suit everyone, and long-term outcomes beyond the 4-week period are not measured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

63 people

The number who actually took part.

Started

Jan 2023

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. ≥ 18 years of age 2. Able to communicate and provide informed consent in English 3. Diagnosis of moderate to severe AUD, based on the Structured Clinical Interview for DSM-5, Research Version (SCID-5-RV) 4. Risky alcohol consumption, defined as \> 10 drinks per week for females and \> 15 drinks for males on average during the 60 days prior to the eligibility assessment. 5. Motivated to abstain from alcohol for the month-long treatment period (longer-term harm reduction goals are permitted) 6. Access to a private location from which to participate in the program for the duration of the study. 7. Able and motivated to complete all aspects of the program, including attending all virtual intensive outpatient program sessions (this includes being available for group and individual sessions throughout the day on weekdays) and completing multiple daily breathalyzer readings throughout the entire program. Individuals planning to be out of the province during the virtual intensive outpatient program will not be permitted to enroll. 8. Enrolled in the Ontario Health Insurance Plan (OHIP) Exclusion Criteria: 1. Severe medical or psychiatric comorbidity that would prevent safe participation in the study 2. Active and severe suicidal ideation at time of eligibility assessment or suicide attempt within the past month. 3. Diagnosis of opioid use disorder or sedative use disorder within the past year based on the SCID-5 (other concurrent substance use disorders such as cannabis use disorder will not be exclusionary) 4. History of alcohol withdrawal delirium 5. Currently pregnant, breastfeeding, or intending to become pregnant or breastfeed during the study. 6. Enrollment in another study that conflicts with the procedures or scientific integrity of this study 7. Individuals planning to be out of the province during the virtual intensive outpatient program will not be permitted to enroll.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre for Addiction and Mental Health

    Toronto, Ontario, M6J 1H4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.